HomeGTBP • NASDAQ
add
GT Biopharma Inc
Previous close
$2.23
Day range
$2.15 - $2.89
Year range
$1.72 - $10.66
Market cap
5.79M USD
Avg Volume
17.15K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.93M | -37.50% |
Net income | -776.00K | 65.75% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.36M | -75.88% |
Total assets | 2.66M | -73.18% |
Total liabilities | 3.64M | -20.91% |
Total equity | -980.00K | — |
Shares outstanding | 2.59M | — |
Price to book | -5.72 | — |
Return on assets | -140.20% | — |
Return on capital | 364.53% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -776.00K | 65.75% |
Cash from operations | -2.20M | 47.11% |
Cash from investing | — | — |
Cash from financing | 616.00K | — |
Net change in cash | -1.59M | -282.09% |
Free cash flow | -3.48M | 9.02% |
About
Founded
1965
Headquarters
Website
Employees
1
